Risk factors for invasive aspergillosis in liver transplant recipients

書誌事項

公開日
2002-11
権利情報
  • http://doi.wiley.com/10.1002/tdm_license_1.1
DOI
  • 10.1053/jlts.2002.36239
公開者
Ovid Technologies (Wolters Kluwer Health)

この論文をさがす

説明

<jats:sec> <jats:title/> <jats:p>Aspergillosis is a potential, severe, and usually early complication of liver transplantation. New promising strategies, such as detecting <jats:italic toggle="yes">Aspergillus</jats:italic> antigenemia, have been used for the diagnosis of aspergillosis in immunosuppressed patients, but the impact in solid organ transplantation is not well known. A case-control study in 260 adults who underwent liver transplantation from January 1994 to June 2000 was performed. A case was defined as any liver transplant recipient with a proven or probable diagnosis of invasive aspergillosis. Controls were defined as a liver transplant recipient without aspergillosis infection with a survival longer than two months after transplantation. Clinical and analytical variables, including <jats:italic toggle="yes">Aspergillus</jats:italic> antigenemia, were compared. A special analysis was performed in patients in whom late aspergillosis developed (after day 100 posttransplantation). Among 260 patients, invasive aspergillosis developed in 15 (5.6%). Median time from transplantation to aspergillosis in 13 patients with sufficient data for analysis was 126 days (range, 22 to 1117). Seven (54%) developed the infection after day 100 posttransplantation. Thirty-eight patients were used as controls. Antigenemia was available in nine of 13 cases and in 33 of 38 controls. By multivariate analysis, retransplantation (OR, 29.9 [95% CI, 2.1 to 425.1]), dialysis requirements after transplantation (OR, 24.5 [95% CI, 1.25 to 354]), and the presence of <jats:italic toggle="yes">Aspergillus</jats:italic> antigenemia in serum at any time point after transplantation (OR, 50.0 [95% CI, 3.56 to 650]) were independently associated to aspergillosis. In the subgroup of patients that developed late aspergillosis, cytomegalovirus infection (OR, 6.7 [95% CI, 1.0 to 42.5]) was the only independent factor associated. Hepatic and renal dysfunction predispose to <jats:italic toggle="yes">Aspergillus</jats:italic> infection in liver transplant recipients. Cytomegalovirus infection and increased immunosuppression favor invasive aspergillosis during the late posttransplantation period. <jats:italic toggle="yes">Aspergillus</jats:italic> antigenemia seems to be a good predictor of invasive aspergillosis.</jats:p> </jats:sec>

収録刊行物

  • Liver Transplantation

    Liver Transplantation 8 (11), 1065-1070, 2002-11

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ